Diffuse Leptomeningeal Glioneuronal Tumors: A Case Series of Five Patients with Parenchymal Forms and an Analysis of the Diagnostic Challenges, Treatment Options and Outcomes

Article ID: e130223213640 Pages: 12

  • * (Excluding Mailing and Handling)

Abstract

Background: Diffuse leptomeningeal glioneuronal tumors (DL-GNT) are rare glioneuronal neoplasms with oligodendroglioma-like cells. These tumors can present as a dominant intracranial mass or as a solitary spinal cord mass without leptomeningeal involvement. In this study, we aimed to determine the magnetic resonance imaging and histopathological features, treatment modalities, and clinical outcomes of the parenchymal forms of DL-GNTs.

Methods: This is a retrospective three-center case series study of 5 patients with a confirmed parenchymal form of DLGTs, out of which 4 patients were adults. Brain and spinal cord MR imaging were performed in all patients at either 1.5 or 3T. The patients' age ranged from 5 years to 50 years with a mean age of 27.6 years at presentation.

Results: Four of the tumors were located in the frontal lobe, and one in the tectum. They were usually solid-cystic enhancing tumors as the other mixed neuronal-glial tumors. All of the tumors had an extension to the superficial surface of a cerebral hemisphere. One had systemic bone metastases. The clinical signs and symptoms of the parenchymal form varied based on the location of the mass, in contrast to the leptomeningeal form associated with hydrocephalus. In one case, the tumor’s initial grade was defined as intermediate. The initial histopathology of the two cases was low-grade and no upgrade occurred in the follow-up period. In two cases, although the tumors were low grade initially, they progressed to an anaplastic form in the follow-up period.

Conclusion: The parenchymal form of DL-GNTs is common in adults. Extension to the superficial surface of a cerebral hemisphere is a distinctive imaging feature. Systemic osseous metastasis may occur. Due to the presence of common histopathological features, including the biphasic composition of glial and neuronal cell elements and oligodendroglioma-like cells, a proposed classification approach might be more beneficial for the histopathological and imaging description, and management of the glioneuronal tumors with oligodendroglioma-like features.

Graphical Abstract

[1]
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro-oncol 2021; 23(8): 1231-51.
[http://dx.doi.org/10.1093/neuonc/noab106] [PMID: 34185076]
[2]
Lakhani DA, Mankad K, Chhabda S, et al. Diffuse leptomeningeal glioneuronal tumor of childhood. AJNR Am J Neuroradiol 2020; 41: 2155-9.
[http://dx.doi.org/10.3174/ajnr.A6737]
[3]
Xu H, Chen F, Zhu H, Luo L, Zhang R. Diffuse leptomeningeal glioneuronal tumor in a Chinese adult: A novel case report and review of literature. Acta Neurol Belg 2020; 120(2): 247-56.
[http://dx.doi.org/10.1007/s13760-019-01262-9] [PMID: 31875302]
[4]
Demir MK. Yapıcıer O, Yılmaz B, Kılıç T. Magnetic resonance imaging findings of mixed neuronal–glial tumors with pathologic correlation: A review. Acta Neurol Belg 2018; 118(3): 379-86.
[http://dx.doi.org/10.1007/s13760-018-0981-1] [PMID: 29987554]
[5]
Appay R, Pages M, Colin C, Jones DTW, Varlet P, Figarella-Branger D. Diffuse leptomeningeal glioneuronal tumor: A double misnomer? A report of two cases. Acta Neuropathol Commun 2020; 8(1): 95.
[http://dx.doi.org/10.1186/s40478-020-00978-7] [PMID: 32605662]
[6]
Yamasaki T, Sakai N, Shinmura K, et al. Anaplastic changes of diffuse leptomeningeal glioneuronal tumor with polar spongioblastoma pattern. Brain Tumor Pathol 2018; 35(4): 209-16.
[http://dx.doi.org/10.1007/s10014-018-0326-z] [PMID: 30051174]
[7]
Deng MY, Sill M, Sturm D, et al. Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) – A molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. Neuropathol Appl Neurobiol 2020; 46(5): 422-30.
[http://dx.doi.org/10.1111/nan.12590] [PMID: 31867747]
[8]
Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ, Kaufmann TJ. 2016 updates to the WHO brain tumor classification system: What the radiologist needs to know. Radiographics 2017; 37(7): 2164-80.
[http://dx.doi.org/10.1148/rg.2017170037] [PMID: 29028423]
[9]
Rodriguez FJ, Perry A, Rosenblum MK, et al. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: A distinctive clinicopathologic entity. Acta Neuropathol 2012; 124(5): 627-41.
[http://dx.doi.org/10.1007/s00401-012-1037-x] [PMID: 22941225]
[10]
Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol 2016; 131(6): 803-20.
[http://dx.doi.org/10.1007/s00401-016-1545-1] [PMID: 27157931]
[11]
Wesseling P, Capper D. WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol 2018; 44(2): 139-50.
[http://dx.doi.org/10.1111/nan.12432] [PMID: 28815663]
[12]
Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 2015; 129(4): 609-10.
[http://dx.doi.org/10.1007/s00401-015-1400-9] [PMID: 25720745]
[13]
Cheng W, He L, Zhu J, Fan X. Diffuse leptomeningeal glioneuronal tumor without KIAA1549-BRAF fusion and 1p detection: A case report and review of literature. Childs Nerv Syst 2022; 38(2): 279-85.
[http://dx.doi.org/10.1007/s00381-021-05426-y] [PMID: 34977973]
[14]
Schwetye KE, Kansagra AP, McEachern J, Schmidt RE, Gauvain K, Dahiya S. Unusual high-grade features in pediatric diffuse leptomeningeal glioneuronal tumor: Comparison with a typical low-grade example. Hum Pathol 2017; 70: 105-12.
[http://dx.doi.org/10.1016/j.humpath.2017.06.004] [PMID: 28652147]
[15]
Teh YG, Azizan N, Mohd Naim NA, Ng CY, Wong KJ, Mohd Zaki F. Case report: Unusual high-grade diffuse leptomeningeal glioneuronal tumor mimicking tuberculous meningitis in a child from an endemic region. Front Pediatr 2021; 9: 767614.
[http://dx.doi.org/10.3389/fped.2021.767614] [PMID: 34956980]
[16]
Al-Ghanem R, Luque Barona R, Godoy-Hurtado A, Galicia Bulnes JM, El-Rubaidi O. Diffuse leptomeningeal glioneuronal tumor: A review of diagnosis and management with an illustrative case. Neurocirugia 2022; 33(6): 389-93.
[http://dx.doi.org/10.1016/j.neucie.2022.02.006]
[17]
Rebella G, Milanaccio C, Morana G, et al. Calcifications in diffuse leptomeningeal glioneuronal tumors: A case series. Quant Imaging Med Surg 2022; 12(5): 2985-94.
[http://dx.doi.org/10.21037/qims-21-741]
[18]
Tiwari N, Tamrazi B, Robison N, Krieger M, Ji J, Tian D. Unusual radiological and histological presentation of a diffuse leptomeningeal glioneuronal tumor (DLGNT) in a 13-year-old girl. Childs Nerv Syst 2019; 35(9): 1609-14.
[http://dx.doi.org/10.1007/s00381-019-04074-7] [PMID: 30770994]
[19]
Kang JH, Buckley AF, Nagpal S, Fischbein N, Peters KB. A diffuse leptomeningeal glioneuronal tumor without diffuse leptomeningeal involvement: Detailed molecular and clinical characterization. J Neuropathol Exp Neurol 2018; 77(9): 751-6.
[http://dx.doi.org/10.1093/jnen/nly053] [PMID: 29931222]
[20]
Pickles JC, Mankad K, Aizpurua M, et al. A case series of Diffuse Glioneuronal Tumours with Oligodendroglioma-like features and Nuclear Clusters (DGONC). Neuropathol Appl Neurobiol 2021; 47(3): 464-7.
[http://dx.doi.org/10.1111/nan.12680] [PMID: 33325069]
[21]
Lee J, Ko H, Choi J, Lee YS, Son B. A case of diffuse leptomeningeal glioneuronal tumor misdiagnosed as chronic tuberculous meningitis without brain biopsy. Case Rep Neurol Med 2018; 2018: 1391943.
[http://dx.doi.org/10.1155/2018/1391943] [PMID: 30112228]
[22]
Aguilera D, Castellino RC, Janss A, et al. Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy. Childs Nerv Syst 2018; 34(2): 329-34.
[http://dx.doi.org/10.1007/s00381-017-3584-x] [PMID: 28965234]
[23]
Sarkinaite M, Devyziene I, Makstiene J, Matukevicius A, Gleizniene R. Diffuse leptomeningeal glioneuronal tumour with 9-year follow-up: Case report and review of the literature. Diagnostics 2022; 12(2): 342.
[http://dx.doi.org/10.3390/diagnostics12020342] [PMID: 35204433]